{"id":"dual-anti-platelet-therapy","safety":{"commonSideEffects":[{"rate":null,"effect":"Bleeding"},{"rate":null,"effect":"Gastrointestinal hemorrhage"},{"rate":null,"effect":"Dyspepsia"},{"rate":null,"effect":"Thrombotic thrombocytopenic purpura (TTP)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This approach typically combines an inhibitor of thromboxane A2 synthesis (such as aspirin) with a P2Y12 receptor antagonist (such as clopidogrel, prasugrel, or ticagrelor) to provide complementary antiplatelet effects. By blocking platelet activation through multiple pathways, dual antiplatelet therapy reduces the risk of stent thrombosis and recurrent ischemic events in cardiovascular disease.","oneSentence":"Dual antiplatelet therapy combines two antiplatelet agents to inhibit platelet aggregation through different mechanisms, reducing thrombotic events.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:10:15.110Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute coronary syndrome"},{"name":"Percutaneous coronary intervention with stent placement"},{"name":"Secondary prevention of myocardial infarction"}]},"trialDetails":[{"nctId":"NCT03574909","phase":"PHASE3","title":"IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes","status":"COMPLETED","sponsor":"Royal College of Surgeons, Ireland","startDate":"2018-09-01","conditions":"Pre-Gestational Diabetes","enrollment":137},{"nctId":"NCT03252249","phase":"PHASE4","title":"Duration of Dual Anti-Platelet Therapy (DUAL-ACS)","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2018-12-11","conditions":"Acute Coronary Syndrome, Coronary Artery Disease","enrollment":5094},{"nctId":"NCT06853535","phase":"PHASE3","title":"Precision Antiplatelet Therapy Guided by Platelet Aggregation Function in Patients With Acute Ischemic STROKE","status":"RECRUITING","sponsor":"Sichuan Provincial People's Hospital","startDate":"2025-05-23","conditions":"Acute Ischemic Stroke, Clopidogrel Resistance","enrollment":5138},{"nctId":"NCT04708587","phase":"NA","title":"Appropriate Duration of Anti-Platelet straTegy in Patients With Advance Chronic Kidney Disease After New Generation Drug Eluting Stents (ADAPT-CKD)","status":"RECRUITING","sponsor":"Yonsei University","startDate":"2021-03-23","conditions":"Chronic Kidney Diseases","enrollment":900},{"nctId":"NCT07307053","phase":"PHASE1, PHASE2","title":"Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)","status":"NOT_YET_RECRUITING","sponsor":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","startDate":"2026-01-01","conditions":"Rare Malignant Neoplasm, Advanced Solid Tumors, Metastatic Solid Tumors","enrollment":600},{"nctId":"NCT02302547","phase":"PHASE3","title":"Trial to Evaluate the Interest of a Reductive Anti Retroviral Strategy Using Dual Therapy Inspite of Triple Therapy","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2014-12","conditions":"HIV","enrollment":224},{"nctId":"NCT05171842","phase":"","title":"Dissection of the Superior Mesenteric Artery","status":"COMPLETED","sponsor":"First Affiliated Hospital of Zhejiang University","startDate":"2021-09-09","conditions":"Dissection of the Superior Mesenteric Artery","enrollment":136},{"nctId":"NCT04624854","phase":"PHASE4","title":"Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD)","status":"COMPLETED","sponsor":"Harbin Medical University","startDate":"2020-10-28","conditions":"Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome","enrollment":8250},{"nctId":"NCT06857045","phase":"NA","title":"Comparison Three vs Six Months of Dual Anti-platelet Therapy After Sirolimus-eluting Stent Implantation","status":"WITHDRAWN","sponsor":"Sino Medical Sciences Technology Inc.","startDate":"2024-07-09","conditions":"Intracranial Arteriosclerosis, Intracranial Artery Stenosis, Drug-Eluting Stents","enrollment":""},{"nctId":"NCT07064707","phase":"PHASE2","title":"Rupatadine in Patients With Ulcerative Colitis","status":"RECRUITING","sponsor":"Alexandria University","startDate":"2025-07-15","conditions":"Ulcerative Colitis","enrollment":60},{"nctId":"NCT06638151","phase":"PHASE2","title":"Clopidogrel Plus Aspirin in Acute Ischemic Stroke Following Thrombectomy and/or Intravenous Thrombolysis (CoPrime)","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2025-09-02","conditions":"Acute Ischemic Stroke","enrollment":200},{"nctId":"NCT07138144","phase":"PHASE4","title":"Efficacy, Safety, and ToLerability of Switching to A Two-Drug Regimen With DTG/3TC Compared to Maintaining A Three-Drug REgimen With BIC/FTC/TAF or DTG/3TC/ABC in ViroLogically SupprEssed PeopLe Living With HIV After 24 and 48 Weeks of Follow-Up","status":"RECRUITING","sponsor":"José Antonio Mata Marín","startDate":"2025-07-12","conditions":"HIV Infections","enrollment":156},{"nctId":"NCT06898151","phase":"NA","title":"Carotid Endarterectomy and Stenting Timing","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2025-03-07","conditions":"Carotid Endarterectomy, Carotid Stenting","enrollment":268},{"nctId":"NCT04483583","phase":"PHASE4","title":"Tailoring P2Y12 Inhibiting Therapy in Patients Requiring Oral Anticoagulation After PCI","status":"COMPLETED","sponsor":"University of Florida","startDate":"2020-12-08","conditions":"Coronary Artery Disease","enrollment":81},{"nctId":"NCT04753749","phase":"NA","title":"Evaluation of a Modified Anti-Platelet Therapy Associated With Low-dose DES Firehawk in Acute Myocardial Infarction Patients Treated With Complete Revascularization Strategy","status":"COMPLETED","sponsor":"MicroPort CRM","startDate":"2021-03-25","conditions":"Myocardial Infarction, Acute, Coronary Artery Disease","enrollment":2248},{"nctId":"NCT07031063","phase":"PHASE4","title":"Safety, Tolerability and Effectiveness of DTG/3TC vs BIC/TAF/FTC in PWH Without Antiretroviral Experience","status":"RECRUITING","sponsor":"Instituto Mexicano del Seguro Social","startDate":"2025-04-01","conditions":"HIV Infection, Metabolic Syndrome, Antiretroviral Treatment","enrollment":124},{"nctId":"NCT06744777","phase":"PHASE3","title":"The Comparative Efficacy of Standard Treatment Plus Ribavirin vs Standard Treatment Alone in Preventing Clinically Significant Hemorrhage in Patients With Dengue Fever","status":"COMPLETED","sponsor":"Khyber Medical University Peshawar","startDate":"2024-12-17","conditions":"Dengue Fever, Dengue Hemorrhagic Fever, Severe Dengue","enrollment":284},{"nctId":"NCT05567562","phase":"PHASE2","title":"Anti-Platelets in Chronic Obstructive Pulmonary Disease","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2024-03-27","conditions":"COPD, Emphysema, Emphysema or COPD","enrollment":19},{"nctId":"NCT06907056","phase":"PHASE4","title":"Effectiveness and Safety of Darunavir/Cobicistat Plus Lamivudine Versus Darunavir/Cobicistat Plus Tenofovir/Emtricitabine in Virologically Suppressed HIV-1-positive Individuals in Mexico","status":"RECRUITING","sponsor":"José Antonio Mata Marín","startDate":"2023-11-09","conditions":"HIV Infection","enrollment":138},{"nctId":"NCT05068414","phase":"","title":"Assessment of the Incidence of Hemorrhagic and Ischemic Events in Post-angioplasty in Anticoagulated Coronary Patients with Atrial Fibrillation","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2021-04-12","conditions":"Atrial Fibrillation, Acute Coronary Syndrome, Thrombosis","enrollment":122},{"nctId":"NCT04250116","phase":"PHASE4","title":"Appropriate Duration of Anti-Platelet and Thrombotic Strategy After 12 Months in Patients With Atrial Fibrillation Treated With Drug Eluting Stents","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yonsei University","startDate":"2020-04-28","conditions":"Atrial Fibrillation","enrollment":960},{"nctId":"NCT03606642","phase":"PHASE2","title":"SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance and Dual Anti-Platelet Therapy","status":"TERMINATED","sponsor":"HonorHealth Research Institute","startDate":"2018-11-19","conditions":"Coronary Artery Disease, Atherosclerosis, Stent Placement","enrollment":50},{"nctId":"NCT03876457","phase":"NA","title":"SELECT2: A Randomized Controlled Trial to Optimize Patient's Selection for Endovascular Treatment in Acute Ischemic Stroke","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2019-10-11","conditions":"Acute Ischemic Stroke","enrollment":352},{"nctId":"NCT03947229","phase":"PHASE4","title":"A Randomized Comparison of CLOpidogrel Monotherapy Versus Extended Dual-antiplatelet Therapy Beyond 12 Months After Implantation of Drug-eluting StEnts in High-risk Lesions or Patients; A-CLOSE Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yonsei University","startDate":"2019-08-14","conditions":"Coronary Artery Disease, DES","enrollment":3200},{"nctId":"NCT04076423","phase":"PHASE4","title":"A Phase IV Study to Assess the Impact of the Change of Antiretroviral Treatment From Dual Therapy to Triple Therapy on Inflammation in Patients With HIV Infection","status":"COMPLETED","sponsor":"Fundacion SEIMC-GESIDA","startDate":"2019-10-10","conditions":"HIV Infections","enrollment":141},{"nctId":"NCT02513914","phase":"NA","title":"Operative Procedures Vs. Endovascular Neurosurgery for Untreated Pseudotumor Trial","status":"SUSPENDED","sponsor":"St. Joseph's Hospital and Medical Center, Phoenix","startDate":"2020-06-03","conditions":"Pseudotumor Cerebri, Idiopathic Intracranial Hypertension (IIH)","enrollment":80},{"nctId":"NCT05070260","phase":"PHASE2, PHASE3","title":"ACTISAVE: ACuTe Ischemic Stroke Study Evaluating Glenzocimab Used as Add-on Therapy Versus placEbo","status":"COMPLETED","sponsor":"Acticor Biotech","startDate":"2021-09-23","conditions":"Acute Ischemic Stroke","enrollment":438},{"nctId":"NCT04240834","phase":"PHASE4","title":"Ticagrelor With Low-dose Versus Regular Aspirin in Patients With Acute Coronary Syndrome (ACS) at High-Risk for Ischemia After Percutaneous Coronary Intervention","status":"RECRUITING","sponsor":"Fu Wai Hospital, Beijing, China","startDate":"2021-02-01","conditions":"Acute Coronary Syndrome, Interventional Cardiology","enrollment":1220},{"nctId":"NCT01556659","phase":"NA","title":"LV Thrombus After Acute AMI: A Randomized Controlled Trial","status":"TERMINATED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2012-03","conditions":"Ventricular Thrombosis Mural Following Myocardial Infarction","enrollment":25},{"nctId":"NCT03896321","phase":"NA","title":"Coronary Artery Ectasia in Elective Coronary Angiography : Predictors, Outcomes and Management","status":"COMPLETED","sponsor":"Assiut University","startDate":"2019-12-01","conditions":"Ectasia, Coronary Artery Disease","enrollment":79},{"nctId":"NCT06071091","phase":"NA","title":"Permanent Intracranial Stenting for Acute Ischemic Stroke Related to a Refractory Large Vessel Occlusion","status":"ACTIVE_NOT_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-11-08","conditions":"Acute Ischemic Stroke","enrollment":346},{"nctId":"NCT06107140","phase":"","title":"Duration of Dual Antiretroviral Therapy in Virologically Suppressed People Living With HIV and Factors Associated With Switching to Tritherapy : a Real-life Cohort","status":"COMPLETED","sponsor":"Tourcoing Hospital","startDate":"2011-01-01","conditions":"HIV Infections","enrollment":580},{"nctId":"NCT06088433","phase":"PHASE4","title":"Ticagrelor Single Antiplatelet Therapy in Patients With High Risk of Bleeding After DCB for Coronary Small Vessel Disease","status":"UNKNOWN","sponsor":"Fu Wai Hospital, Beijing, China","startDate":"2023-11-15","conditions":"Coronary Heart Disease","enrollment":292},{"nctId":"NCT05885932","phase":"NA","title":"Drug-eluting Stenting Versus Medical Treatment for Extracranial Vertebral Artery Stenosis","status":"RECRUITING","sponsor":"Xuanwu Hospital, Beijing","startDate":"2023-08-25","conditions":"Ischemic Stroke, Vertebral Artery Stenosis","enrollment":472},{"nctId":"NCT05936606","phase":"NA","title":"Tailored Anti-platelet Therapy After DES Implantation in High-risk Patients","status":"RECRUITING","sponsor":"Yonsei University","startDate":"2023-08-16","conditions":"Coronary Artery Disease","enrollment":3434},{"nctId":"NCT05892042","phase":"NA","title":"Anti-CoagulaTion on Left Ventricular Thrombus After ST Segment Elevation Myocardial Infarction","status":"UNKNOWN","sponsor":"Jilin University","startDate":"2023-05-01","conditions":"ST-segment Elevation Myocardial Infarction (STEMI), Left Ventricular Thrombus","enrollment":320},{"nctId":"NCT04006288","phase":"PHASE4","title":"Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease","status":"COMPLETED","sponsor":"University of Florida","startDate":"2019-09-06","conditions":"Coronary Artery Disease","enrollment":90},{"nctId":"NCT05820048","phase":"PHASE4","title":"The Efficacy and Safty of Proton Pump Inhibitor (Lansoprazole)","status":"UNKNOWN","sponsor":"Daejeon St. Mary's hospital","startDate":"2023-05-01","conditions":"Coronary Artery Disease","enrollment":300},{"nctId":"NCT05705089","phase":"PHASE3","title":"Rivaroxaban vErsus Warfarin for Antithrombotic TheRapy in Patients With LeFt Ventricular Thrombus After Acute STEMI","status":"COMPLETED","sponsor":"Rajaie Cardiovascular Medical and Research Center","startDate":"2020-07-30","conditions":"Left Ventricular Thrombus, ST Segment Elevation Myocardial Infarction","enrollment":50},{"nctId":"NCT02144831","phase":"PHASE4","title":"The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic Attack","status":"WITHDRAWN","sponsor":"University of Alberta","startDate":"2014-07","conditions":"Transient Ischemic Attacks, Minor Stroke","enrollment":""},{"nctId":"NCT05375435","phase":"PHASE4","title":"Efficacy and Safety of Triple Therapy in Patients With Anti-MDA5 Antibody-positive Dermatomyositis","status":"UNKNOWN","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2022-01-01","conditions":"Dermatomyositis, Adult Type, Interstitial Lung Disease","enrollment":120},{"nctId":"NCT05374265","phase":"NA","title":"Cardiovascular Magnetic Resonance Guided Open Artery Trial for Revascularization of Late Presenting ST Elevation Myocardial Infarction","status":"WITHDRAWN","sponsor":"Sheffield Teaching Hospitals NHS Foundation Trust","startDate":"2022-06-01","conditions":"STEMI","enrollment":""},{"nctId":"NCT05295394","phase":"PHASE4","title":"Dolutegravir-Lamivudine as Dual Therapy in naïve HIV-Infected Patients With Documented M184V Mutation:A Pilot Study","status":"WITHDRAWN","sponsor":"Pedro Cahn","startDate":"2019-05-22","conditions":"HIV-1 Infection","enrollment":""},{"nctId":"NCT04088513","phase":"PHASE4","title":"Safety and Efficacy of Aspirin in Stroke Patients With Glucose-6-phosphate Dehydrogenase Deficiency (SAST)","status":"UNKNOWN","sponsor":"First Affiliated Hospital, Sun Yat-Sen University","startDate":"2020-01-22","conditions":"G6PD Deficiency, Stroke","enrollment":440},{"nctId":"NCT01452152","phase":"PHASE4","title":"Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study","status":"TERMINATED","sponsor":"University of Maryland, Baltimore","startDate":"2012-02","conditions":"Cardiovascular Diseases, Acute Coronary Syndrome","enrollment":9},{"nctId":"NCT01813435","phase":"PHASE3","title":"GLOBAL LEADERS: A Clinical Study Comparing Two Forms of Anti-platelet Therapy After Stent Implantation","status":"COMPLETED","sponsor":"ECRI bv","startDate":"2013-07-01","conditions":"Coronary Artery Disease (CAD)","enrollment":15991},{"nctId":"NCT02348359","phase":"PHASE2","title":"X-82 to Treat Age-related Macular Degeneration","status":"TERMINATED","sponsor":"Tyrogenex","startDate":"2015-03-16","conditions":"Age-Related Macular Degeneration (AMD), Macular Degeneration, Exudative Age-related Macular Degeneration","enrollment":157},{"nctId":"NCT01925794","phase":"NA","title":"COBRA PZF™ Coronary Stent for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term DAPT","status":"COMPLETED","sponsor":"CeloNova BioSciences, Inc.","startDate":"2013-08-21","conditions":"Coronary Artery Disease","enrollment":296},{"nctId":"NCT04885816","phase":"NA","title":"Drug-eluting Balloon Versus Drug-eluting Stent for High Bleeding Risk Angioplasty","status":"TERMINATED","sponsor":"Instituto Nacional de Cardiologia Ignacio Chavez","startDate":"2021-04-20","conditions":"High Bleeding Risk, Coronary Artery Disease (CAD), Percutaneous Coronary Intervention (PCI)","enrollment":5},{"nctId":"NCT03803007","phase":"PHASE1, PHASE2","title":"Acute Ischemic Stroke Interventional Study","status":"COMPLETED","sponsor":"Acticor Biotech","startDate":"2019-03-06","conditions":"Acute Ischemic Stroke","enrollment":160},{"nctId":"NCT04090281","phase":"PHASE4","title":"Implementing Precision Medicine Approaches to Guide Anti-platelet Selection","status":"UNKNOWN","sponsor":"University of Southern California","startDate":"2020-03-13","conditions":"Acute Coronary Syndrome (ACS), STEMI - ST Elevation Myocardial Infarction (MI), NSTEMI - Non-ST Segment Elevation MI","enrollment":200},{"nctId":"NCT03615846","phase":"","title":"Comparison of the VerifyNow® Aspirin Test and PRUTest® Platelet Reactivity Tests With Investigational Reagent to Reagents Registered in Japan","status":"UNKNOWN","sponsor":"Accriva Diagnostics","startDate":"2021-02-15","conditions":"Platelet Aggregation, Coronary Artery Disease","enrollment":147},{"nctId":"NCT04995159","phase":"NA","title":"Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVas™ BRS System","status":"NOT_YET_RECRUITING","sponsor":"Lepu Medical Technology (Beijing) Co., Ltd.","startDate":"2021-09","conditions":"Coronary Heart Disease","enrollment":2150},{"nctId":"NCT01585259","phase":"PHASE1, PHASE2","title":"Anfibatide Phase Ib-IIa Clinical Trial","status":"COMPLETED","sponsor":"Lee's Pharmaceutical Limited","startDate":"2012-07","conditions":"Non-ST Segment Elevation Myocardial Infarction","enrollment":90},{"nctId":"NCT03813134","phase":"NA","title":"Testing the Value of Novel Strategy and Its Cost Efficacy in Order to Improve the Poor Outcomes in Cardiogenic Shock","status":"UNKNOWN","sponsor":"University of Leicester","startDate":"2019-10-11","conditions":"Cardiogenic Shock","enrollment":428},{"nctId":"NCT01300611","phase":"PHASE1","title":"TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation","status":"TERMINATED","sponsor":"Tarix Pharmaceuticals","startDate":"2011-01","conditions":"Double Cord Blood Transplant, Acute Myelogenous Leukemia, Myelodysplastic Syndrome","enrollment":20},{"nctId":"NCT04620109","phase":"PHASE1","title":"Clinical Evaluation of Safety and Tolerability of KDR2-2 Eye Drops in Healthy Volunteers With Pharmacokinetic Assessment","status":"UNKNOWN","sponsor":"Guangzhou HuiBoRui Biological Pharmaceutical Technology Co. Ltd","startDate":"2020-08-26","conditions":"Corneal Neovascularization","enrollment":62},{"nctId":"NCT02594501","phase":"NA","title":"Randomized Trial of COBRA PzF Stenting to Reduce Duration of Triple Therapy","status":"UNKNOWN","sponsor":"CeloNova BioSciences, Inc.","startDate":"2016-02-05","conditions":"Angina, Stable, Angina, Unstable, Anticoagulants","enrollment":996},{"nctId":"NCT00963781","phase":"PHASE4","title":"Scripps Evaluation of Antiplatelet Therapies for Intermediate Duration With the Endeavor Stent (Seaside)","status":"COMPLETED","sponsor":"Scripps Health","startDate":"2009-08","conditions":"Coronary Artery Disease, Coronary Thrombosis","enrollment":219},{"nctId":"NCT02224235","phase":"NA","title":"COBRA SHIELD OCT Study","status":"TERMINATED","sponsor":"CeloNova BioSciences, Inc.","startDate":"2014-06","conditions":"Stable Angina","enrollment":8},{"nctId":"NCT03287167","phase":"PHASE4","title":"Comparison One vs Six Months of Dual Antiplatelet Therapy After Implanted Firehawk TM Stent in High Bleeding Risk Patients With Coronary Artery Disease","status":"UNKNOWN","sponsor":"Shanghai MicroPort Medical (Group) Co., Ltd.","startDate":"2019-06-01","conditions":"Coronary Disease, Drug Eluting Stent, Percutaneous Coronary Intervention","enrollment":1720},{"nctId":"NCT03008083","phase":"PHASE4","title":"Comparison Three vs Twelve Months of Dual Anti-Platelet Therapy After Stent Implantation","status":"UNKNOWN","sponsor":"Shanghai MicroPort Medical (Group) Co., Ltd.","startDate":"2019-01-10","conditions":"Drug-Eluting Stents, Percutaneous Coronary Intervention","enrollment":2446},{"nctId":"NCT02377388","phase":"PHASE3","title":"DPP-4 Inhibitors and Acute Myocardial Infarction:Effects on Platelet Function","status":"COMPLETED","sponsor":"University of Sao Paulo General Hospital","startDate":"2017-02-07","conditions":"Platelet Aggregation During Acute Myocardial Infarction","enrollment":74},{"nctId":"NCT02789917","phase":"PHASE4","title":"APixaban vs. PhenpRocoumon in Patients With ACS and AF: APPROACH-ACS-AF","status":"COMPLETED","sponsor":"LMU Klinikum","startDate":"2016-06","conditions":"Acute Coronary Syndrome, Atrial Fibrillation, Coronary Artery Disease","enrollment":403},{"nctId":"NCT04492501","phase":"NA","title":"Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan","status":"COMPLETED","sponsor":"UNICEF","startDate":"2020-04-01","conditions":"Covid19, Cytokine Release Syndrome, Critical Illness","enrollment":600},{"nctId":"NCT02506140","phase":"PHASE2, PHASE3","title":"Platelet Reactivity in Acute Non-disabling Cerebrovascular Events","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2015-08","conditions":"Stroke, Ischemic Attack, Transient","enrollment":675},{"nctId":"NCT03848572","phase":"NA","title":"Repetitive Assessement of PRECISE-DAPT Score","status":"COMPLETED","sponsor":"University of Roma La Sapienza","startDate":"2017-06-01","conditions":"Cardiovascular Diseases, Interventional Cardiology","enrollment":500},{"nctId":"NCT02548650","phase":"PHASE4","title":"Vorapaxar as an Add-On Antiplatelet Therapy in Patients With and Without Diabetes Mellitus","status":"COMPLETED","sponsor":"University of Florida","startDate":"2016-03-25","conditions":"Myocardial Infarction, Diabetes Mellitus, Peripheral Arterial Disease","enrollment":66},{"nctId":"NCT03746782","phase":"","title":"Apixaban + DAPT in Lowering Platelet Reactivity and Thrombin Generation","status":"COMPLETED","sponsor":"CirQuest Labs, LLC","startDate":"2018-07-10","conditions":"Acute Coronary Syndrome","enrollment":40},{"nctId":"NCT01327846","phase":"PHASE3","title":"Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2011-04-11","conditions":"Atherosclerosis","enrollment":10066},{"nctId":"NCT04163237","phase":"PHASE3","title":"Combined Immunotherapy and Targeted Therapy for Advanced Liver Cancer","status":"UNKNOWN","sponsor":"Guangxi Medical University","startDate":"2019-12-01","conditions":"Advanced Liver Cancer","enrollment":50},{"nctId":"NCT04152356","phase":"","title":"Combined Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma","status":"UNKNOWN","sponsor":"Guangxi Medical University","startDate":"2019-11-01","conditions":"HepatoCellular Carcinoma","enrollment":50},{"nctId":"NCT03459248","phase":"NA","title":"Metoclopramide-Ondansetron vs. Metoclopramide Therapy for Treatment of Nausea and Vomiting Post Laparoscopic Surgery","status":"COMPLETED","sponsor":"Makassed General Hospital","startDate":"2018-02-15","conditions":"Postoperative Nausea and Vomiting","enrollment":120},{"nctId":"NCT03224923","phase":"PHASE4","title":"A Novel Strategy For Personalized Long-Term Dual Antiplatelet Therapy (RAPID EXTEND PILOT STUDY)","status":"TERMINATED","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2017-08-18","conditions":"Stable Coronary Syndrome, Percutaneous Coronary Intervention, Antiplatelet Therapy","enrollment":5},{"nctId":"NCT04021173","phase":"PHASE2","title":"A Clinical Study of Anfibatide in Acquired Thrombotic Thrombocytopenic Purpura (TTP)","status":"UNKNOWN","sponsor":"Lee's Pharmaceutical Limited","startDate":"2019-07","conditions":"Acquired Thrombotic Thrombocytopenic Purpura","enrollment":74},{"nctId":"NCT02118870","phase":"PHASE4","title":"Short-term Dual Anti Platelet Therapy in Patients With ACS Treated With the COMBO Dual-therapy Stent","status":"COMPLETED","sponsor":"Diagram B.V.","startDate":"2014-06-10","conditions":"Acute Coronary Syndrome","enrollment":1500},{"nctId":"NCT02494895","phase":"PHASE4","title":"Ticagrelor Monotherapy After 3 Months in the Patients Treated With New Generation Sirolimus Stent for Acute Coronary Syndrome (TICO Study)","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2015-08-01","conditions":"Acute Coronary Syndrome","enrollment":3056},{"nctId":"NCT02265068","phase":"","title":"Real Life Long-term Adherence to Ticagrelor After PCI for Acute Coronary Syndromes","status":"COMPLETED","sponsor":"IHF GmbH - Institut für Herzinfarktforschung","startDate":"2014-08","conditions":"Acute Coronary Syndrome (ACS)","enrollment":700},{"nctId":"NCT03435731","phase":"NA","title":"Dual Obstructive Sleep Apnea Therapy","status":"UNKNOWN","sponsor":"University of British Columbia","startDate":"2018-03-08","conditions":"Obstructive Sleep Apnea","enrollment":30},{"nctId":"NCT01245725","phase":"PHASE3","title":"Aggrastat Truncated Length Against Standard Therapies in Percutaneous Coronary Intervention","status":"WITHDRAWN","sponsor":"Medicure","startDate":"","conditions":"Myocardial Infarction, Acute Coronary Syndromes, Unstable Angina","enrollment":""},{"nctId":"NCT01359423","phase":"NA","title":"Comparison of Primary Long Full Coverage Stenting vs Primary Short Spot Stenting for Long Femoropopliteal Artery Disease.","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2011-09-26","conditions":"Claudication","enrollment":89},{"nctId":"NCT02383771","phase":"PHASE4","title":"Reversal of the Anti-platelet Effects of Ticagrelor","status":"COMPLETED","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2015-03","conditions":"Coronary Artery Disease","enrollment":64},{"nctId":"NCT02227368","phase":"PHASE2","title":"Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR","status":"TERMINATED","sponsor":"AstraZeneca","startDate":"2014-10-20","conditions":"Peripheral Artery Disease (PAD)","enrollment":40},{"nctId":"NCT01779401","phase":"NA","title":"Clopidogrel Response Evaluation and AnTi-Platelet InterVEntion in High Thrombotic Risk PCI Patients","status":"COMPLETED","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2012-09","conditions":"Coronary Heart Disease","enrollment":1078},{"nctId":"NCT02330640","phase":"PHASE4","title":"A Single-center, Prospective,Randomized Study of Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Dual Anti-platelet Therapy After Coronary Artery Bypass Grafting","status":"COMPLETED","sponsor":"Chinese Academy of Medical Sciences, Fuwai Hospital","startDate":"2016-01","conditions":"Antiplatelet Therapy of Coronary Artery Bypass","enrollment":137},{"nctId":"NCT03103685","phase":"PHASE4","title":"Continue vs. Stop P2Y12 Inhibitor on Bleeding in Patient Receiving DAPT Undergoing Dental Procedure.","status":"UNKNOWN","sponsor":"Chiang Mai University","startDate":"2017-05-01","conditions":"Dental Diseases, Antiplatelet Agents, Antiplatelet Drugs","enrollment":428},{"nctId":"NCT03056118","phase":"PHASE4","title":"Optimal Duration of Clopidogrel in Second-Generation Drug-Eluting Stents","status":"COMPLETED","sponsor":"Gangnam Severance Hospital","startDate":"2011-05-02","conditions":"Ischemic Heart Disease","enrollment":1368},{"nctId":"NCT01561950","phase":"PHASE1","title":"Efficacy of Activated Recombinant Human Factor VII in Healthy Volunteers Treated for Punch Biopsy Mediated Bleeding","status":"TERMINATED","sponsor":"Novo Nordisk A/S","startDate":"2008-05","conditions":"Haemostasis, Healthy","enrollment":91},{"nctId":"NCT01308281","phase":"NA","title":"Impact of IntraVascular UltraSound Guidance on Outcomes of Xience Prime Stents in Long Lesions (IVUS-XPL Study)","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2010-10","conditions":"Coronary Artery Disease","enrollment":1079},{"nctId":"NCT02707445","phase":"NA","title":"Genotyping Influences Outcome of Coronary Artery Stenting","status":"COMPLETED","sponsor":"Korea University Anam Hospital","startDate":"2011-09","conditions":"Myocardial Ischemia, CLOPIDOGREL, POOR METABOLISM of (Disorder)","enrollment":5000},{"nctId":"NCT00998127","phase":"","title":"Patterns of Non-Adherence to Dual Anti-Platelet Regimen In Stented Patients","status":"COMPLETED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2009-06","conditions":"Medication Non-adherence, Stent Thrombosis","enrollment":5031},{"nctId":"NCT01659034","phase":"PHASE4","title":"Short and Optimal Duration of Dual Antiplatelet Therapy Study","status":"COMPLETED","sponsor":"Takeshi Morimoto","startDate":"2012-09","conditions":"Coronary Artery Disease","enrollment":1525},{"nctId":"NCT02618265","phase":"NA","title":"Mobile Terminal Based Management of Stroke Secondary Prevention Adminstration Effect Research","status":"UNKNOWN","sponsor":"Peking University Third Hospital","startDate":"2016-01","conditions":"Stroke","enrollment":400},{"nctId":"NCT01346865","phase":"PHASE4","title":"Drug-Eluting Stenting Followed by Cilostazol tREAtment Reduces SErious Adverse Cardiac Events (DECREASE-PCI)","status":"TERMINATED","sponsor":"Seung-Jung Park","startDate":"2011-05","conditions":"Coronary Artery Disease","enrollment":402},{"nctId":"NCT01358422","phase":"","title":"Occurrence of Bleeding and Thrombosis During Antiplatelet Therapy in Non-cardiac Surgery","status":"COMPLETED","sponsor":"European Society of Anaesthesiology","startDate":"2011-10","conditions":"Bleeding, Thrombosis, Cardiac Events","enrollment":830},{"nctId":"NCT02348021","phase":"PHASE3","title":"Leaders Free Japan","status":"UNKNOWN","sponsor":"Biosensors Europe SA","startDate":"2014-07","conditions":"Coronary Disease","enrollment":139},{"nctId":"NCT00269893","phase":"PHASE3","title":"A Study Evaluating the Efficacy and Safety of Abciximab, an Anti-platelet Therapy, in Patients Undergoing High-risk Coronary Angioplasty","status":"COMPLETED","sponsor":"Centocor, Inc.","startDate":"1991-11","conditions":"Angina, Unstable, Angioplasty, Transluminal, Percutaneous Coronary","enrollment":2038},{"nctId":"NCT00269880","phase":"PHASE3","title":"A Study Comparing the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Combination With Two Different Heparin Regimens in Patients Undergoing Percutaneous Coronary Intervention.","status":"COMPLETED","sponsor":"Centocor, Inc.","startDate":"1995-02","conditions":"Angioplasty, Transluminal, Percutaneous Coronary","enrollment":2792},{"nctId":"NCT00238667","phase":"PHASE3","title":"To Determine the Feasibility of a Clinical Trial Comparing Anticoagulants Versus Antiplatelets in the Acute Treatment of Patients With Cervical Artery Dissection","status":"COMPLETED","sponsor":"St George's, University of London","startDate":"2005-11","conditions":"Cervical Artery Dissection, Carotid Artery Dissection, Vertebral Artery Dissection","enrollment":250},{"nctId":"NCT00896337","phase":"PHASE3","title":"EPIC Nitinol Stent System in the Treatment of Atherosclerotic Lesions in Iliac Arteries","status":"COMPLETED","sponsor":"Boston Scientific Corporation","startDate":"2009-05","conditions":"Iliac Artery Stenosis","enrollment":125}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"ABDOMINAL PAIN"},{"count":1,"reaction":"CHRONIC KIDNEY DISEASE"},{"count":1,"reaction":"CHRONIC OBSTRUCTIVE PULMONARY DISEASE"},{"count":1,"reaction":"COLITIS ISCHAEMIC"},{"count":1,"reaction":"DEFAECATION URGENCY"},{"count":1,"reaction":"DRUG HYPERSENSITIVITY"},{"count":1,"reaction":"DYSLIPIDAEMIA"},{"count":1,"reaction":"GOUT"},{"count":1,"reaction":"HAEMATOCHEZIA"},{"count":1,"reaction":"HAEMOGLOBIN DECREASED"}],"_approvalHistory":[],"publicationCount":432,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Dual Anti Platelet Therapy","genericName":"Dual Anti Platelet Therapy","companyName":"Biosensors Europe SA","companyId":"biosensors-europe-sa","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Dual antiplatelet therapy combines two antiplatelet agents to inhibit platelet aggregation through different mechanisms, reducing thrombotic events. Used for Acute coronary syndrome, Percutaneous coronary intervention with stent placement, Secondary prevention of myocardial infarction.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}